MX2015016519A - Composiciones y metodo para controlar infecciones en mamiferos no humanos utilizando proteinas de fase aguda. - Google Patents

Composiciones y metodo para controlar infecciones en mamiferos no humanos utilizando proteinas de fase aguda.

Info

Publication number
MX2015016519A
MX2015016519A MX2015016519A MX2015016519A MX2015016519A MX 2015016519 A MX2015016519 A MX 2015016519A MX 2015016519 A MX2015016519 A MX 2015016519A MX 2015016519 A MX2015016519 A MX 2015016519A MX 2015016519 A MX2015016519 A MX 2015016519A
Authority
MX
Mexico
Prior art keywords
human mammals
compositions
infections
acute phase
phase proteins
Prior art date
Application number
MX2015016519A
Other languages
English (en)
Inventor
Alejandro Bach Ariza
Sylvia Pares
Anna Domenech
Anna Aris
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of MX2015016519A publication Critical patent/MX2015016519A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1716—Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y116/00—Oxidoreductases oxidizing metal ions (1.16)
    • C12Y116/03—Oxidoreductases oxidizing metal ions (1.16) with oxygen as acceptor (1.16.3)
    • C12Y116/03001—Ferroxidase (1.16.3.1), i.e. ceruloplasmin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a composiciones y métodos para controlar infecciones en mamíferos no humanos, particularmente infecciones intra-mamarias (IMI). La invención es particularmente adecuada para controlar infecciones y aumentar el bienestar de mamíferos no humanos, preferentemente bovinos, mejorando la involución de la glándula mamaria durante el periodo de secado. La invención se basa en el uso de proteínas de fase aguda, más preferentemente seroamiloide A (SAA), incluso más preferentemente la isoforma 3 (SAA-3).
MX2015016519A 2013-06-06 2014-06-05 Composiciones y metodo para controlar infecciones en mamiferos no humanos utilizando proteinas de fase aguda. MX2015016519A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13170932.1A EP2810695A1 (en) 2013-06-06 2013-06-06 Compositions and Method for controlling infections in non-human mammals using acute phase proteins
PCT/EP2014/061717 WO2014195413A1 (en) 2013-06-06 2014-06-05 Compositions and method for controlling infections in non-human mammals using acute phase proteins

Publications (1)

Publication Number Publication Date
MX2015016519A true MX2015016519A (es) 2016-04-15

Family

ID=48569996

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016519A MX2015016519A (es) 2013-06-06 2014-06-05 Composiciones y metodo para controlar infecciones en mamiferos no humanos utilizando proteinas de fase aguda.

Country Status (10)

Country Link
US (1) US20160310565A1 (es)
EP (2) EP2810695A1 (es)
CN (1) CN105407972B (es)
AU (1) AU2014276875B2 (es)
CA (1) CA2912153C (es)
ES (1) ES2831623T3 (es)
MX (1) MX2015016519A (es)
NZ (1) NZ713734A (es)
RU (1) RU2725841C2 (es)
WO (1) WO2014195413A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11464831B2 (en) 2015-01-05 2022-10-11 Cornell University Compositions and methods using IL-8 for improving health of mammals
AU2016205456B2 (en) 2015-01-05 2021-10-07 Cornell University Compositions and methods using IL-8 to improve milk production and reproductive health in mammals
CN108727484B (zh) * 2017-04-24 2022-02-01 上海交通大学 人血清淀粉样蛋白a1功能性短肽及其制备方法和应用
CN108489941B (zh) * 2018-01-31 2021-07-27 吉林大学 溴酚蓝在作为检测牛胰岛素淀粉样纤维探针和作为牛胰岛素淀粉样纤维抑制剂方面的应用
CN113717268B (zh) * 2021-09-27 2023-07-07 北京市水产科学研究所（国家淡水渔业工程技术研究中心） 锦鲤血清淀粉样蛋白a5或其编码基因在调控锦鲤抗病原菌感染中的应用
CN116444649B (zh) * 2022-11-30 2024-05-24 内蒙古伊利实业集团股份有限公司 乳源活性肽gitdplfkgm、gitdplfkg及其获得方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951839A (en) * 1959-07-15 1960-09-06 Doyle Frank Peter Synthetic penicillins
US4034099A (en) * 1974-03-29 1977-07-05 The Upjohn Company Compositions and method for treating mastitis in milk animals
AU689494B2 (en) * 1993-08-20 1998-04-02 Boehringer Ingelheim Vetmedica Gmbh Method for the prevention and treatment of bovine mastitis
CA2220708A1 (en) * 1995-06-01 1996-12-05 Queen's University At Kingston Serum amyloid a protein
US20050107315A1 (en) * 2001-11-21 2005-05-19 Board Of Regents Of The University Of Nebraska Mammary-associated serum amuloid a3 promoter sequences and used for same
US7368546B2 (en) * 2003-01-21 2008-05-06 The Board Of Regents Of The University Of Nebraska Human SAA3 nucleic acid molecule, protein, and methods of use for same
US7557081B2 (en) * 2004-05-27 2009-07-07 Essential Skincare, Llc Alpha-1-acid glycoprotein for the treatment of diabetes
BRPI0611301A2 (pt) * 2005-05-02 2010-08-31 Mileutis Ltd composicões farmacêuticas compreendendo peptìdeos derivados da caseìna e métodos de uso das mesmas
US7678561B2 (en) * 2006-05-09 2010-03-16 The Scripps Research Institute Robust expression of a bioactive mammalian protein in chlamydomonas chloroplast
HUE028190T2 (en) * 2010-03-22 2016-12-28 Reinhold Paul Linke SAA containing pharmaceutical composition for use in the treatment of acute and chronic inflammatory diseases and conditions
US20130330294A1 (en) * 2010-11-08 2013-12-12 The Board Of Trustees Of The Leland Stanford Junior University Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy
US20120226261A1 (en) * 2011-02-08 2012-09-06 The Curators Of The University Of Missouri Intramammary Injection Device
US9873731B2 (en) * 2014-09-15 2018-01-23 The Lauridsen Group Incorporated Method for increasing milk production by ruminants

Also Published As

Publication number Publication date
CN105407972B (zh) 2021-12-24
CA2912153A1 (en) 2014-12-11
WO2014195413A1 (en) 2014-12-11
RU2725841C2 (ru) 2020-07-06
AU2014276875A1 (en) 2015-11-12
AU2014276875B2 (en) 2019-08-08
EP3003488A1 (en) 2016-04-13
RU2015155830A (ru) 2017-07-17
NZ713734A (en) 2020-08-28
CN105407972A (zh) 2016-03-16
RU2015155830A3 (es) 2018-03-21
CA2912153C (en) 2023-09-26
US20160310565A1 (en) 2016-10-27
ES2831623T3 (es) 2021-06-09
EP2810695A1 (en) 2014-12-10
EP3003488B1 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
MX2015016519A (es) Composiciones y metodo para controlar infecciones en mamiferos no humanos utilizando proteinas de fase aguda.
BR112021006412A2 (pt) método de predição intra e dispositivo
MY180106A (en) Method of reducing exercise-induced joint pain in non-arthritic mammals
CL2018000226A1 (es) Mezcla de péptidos (divisional solicitud 201601405)
BR112017023862A2 (pt) anticorpos anti-cd71, anticorpos anti-cd71 ativáveis, e métodos de uso destes
BR112017025574A2 (pt) composições e métodos para degradação de proteínas de má dobra
EA201791223A1 (ru) Процесс для управления уровнем содержания гликанов гликопротеина
BR112015019879A2 (pt) Composições de espécies de variantes moduladas de lisina e métodos para produção e uso das mesmas
BR112016001917A2 (pt) métodos e aparelho para comutar um estado, e terminal de controle
ZA202208710B (en) Anti-vegf protein compositions and methods for producing the same
MX2015012872A (es) Anticuerpos anti-tau y metodos de uso.
MX2018001536A (es) Metodo para la reduccion de proteinas de celulas hospederas en cromatografia de afinidad.
BR112017001417A2 (pt) variantes de proteína de ligação ao fator h e métodos para uso das mesmas
BR112015006023A2 (pt) métodos e aparelhos para estimar uma condição de uma vedação de uma válvula rotativa
EA201690269A1 (ru) Способы контроля уровней фукозилирования в белках
BR112013017799A2 (pt) dispositivo de criptografia de vídeo, dispositivo de decodificação de víde, método de criptografia de vídeo, método de decodificação de vídeo e programa de criptografia de vídeo
EA201792608A2 (ru) Применение белков p3 бактериофага в качестве агентов, связывающих амилоид
EP3572507A4 (en) EXPRESSION METHOD FOR RECOMBINANT HAEMOCOAGULASE ACUTUS PROTEIN
EA202191909A1 (ru) Регулирование метаболизма орнитина для управления содержанием высокоманнозных гликоформ рекомбинантных белков
WO2015030585A3 (en) Methods for detecting post-translationally modified lysines in a polypeptide
EA201792020A1 (ru) Система для опционного динамического позиционирования лыжного крепления
MX2016015615A (es) Control de la formacion de enlaces disulfuro en disoluciones de proteinas mediante la adicion de agentes reductores.
EP3666897A4 (en) VERY VERSATILE PROCESS FOR REPRESENTING A CYCLIC PEPTID ON A PROTEIN STRUCTURE
BR112016016672A2 (pt) Uso de uma composição
BR112018005464A2 (pt) expressão de proteínas contendo fc

Legal Events

Date Code Title Description
FG Grant or registration